Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity
- PMID: 33385714
- PMCID: PMC7831793
- DOI: 10.1016/j.intimp.2020.107276
Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity
Abstract
SARS-CoV-2 has a high transmission rate and shows frequent mutations, thus making vaccine development an arduous task. However, researchers around the globe are working hard to find a solution e.g. synthetic vaccine. Here, we have performed genome-wide analysis of 566 Indian SARS-CoV-2 genomes to extract the potential conserved regions for identifying peptide based synthetic vaccines, viz. epitopes with high immunogenicity and antigenicity. In this regard, different multiple sequence alignment techniques are used to align the SARS-CoV-2 genomes separately. Subsequently, consensus conserved regions are identified after finding the conserved regions from each aligned result of alignment techniques. Further, the consensus conserved regions are refined considering that their lengths are greater than or equal to 60nt and their corresponding proteins are devoid of any stop codons. Subsequently, their specificity as query coverage are verified using Nucleotide BLAST. Finally, with these consensus conserved regions, T-cell and B-cell epitopes are identified based on their immunogenic and antigenic scores which are then used to rank the conserved regions. As a result, we have ranked 23 consensus conserved regions that are associated with different proteins. This ranking also resulted in 34 MHC-I and 37 MHC-II restricted T-cell epitopes with 16 and 19 unique HLA alleles and 29 B-cell epitopes. After ranking, the consensus conserved region from NSP3 gene is obtained that is highly immunogenic and antigenic. In order to judge the relevance of the identified epitopes, the physico-chemical properties and binding conformation of the MHC-I and MHC-II restricted T-cell epitopes are shown with respect to HLA alleles.
Keywords: B-cell epitopes; Conserved regions; Peptide based vaccine; Physico-chemical properties; SARS-CoV-2; T-cell epitopes.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures








Similar articles
-
Bioinformatics pipeline unveils genetic variability to synthetic vaccine design for Indian SARS-CoV-2 genomes.Int Immunopharmacol. 2022 Nov;112:109224. doi: 10.1016/j.intimp.2022.109224. Epub 2022 Sep 6. Int Immunopharmacol. 2022. PMID: 36116149 Free PMC article.
-
Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes.Infect Genet Evol. 2021 Aug;92:104823. doi: 10.1016/j.meegid.2021.104823. Epub 2021 Apr 2. Infect Genet Evol. 2021. PMID: 33819681 Free PMC article.
-
Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening.Biomed Res Int. 2021 Feb 26;2021:1596834. doi: 10.1155/2021/1596834. eCollection 2021. Biomed Res Int. 2021. PMID: 33728324 Free PMC article.
-
Development of multi-epitope peptide-based vaccines against SARS-CoV-2.Biomed J. 2021 Mar;44(1):18-30. doi: 10.1016/j.bj.2020.09.005. Epub 2020 Oct 1. Biomed J. 2021. PMID: 33727051 Free PMC article. Review.
-
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.Front Immunol. 2020 Sep 3;11:2008. doi: 10.3389/fimmu.2020.02008. eCollection 2020. Front Immunol. 2020. PMID: 33013857 Free PMC article. Review.
Cited by
-
Bioinformatics pipeline unveils genetic variability to synthetic vaccine design for Indian SARS-CoV-2 genomes.Int Immunopharmacol. 2022 Nov;112:109224. doi: 10.1016/j.intimp.2022.109224. Epub 2022 Sep 6. Int Immunopharmacol. 2022. PMID: 36116149 Free PMC article.
-
Mapping Potential Vaccine Candidates Predicted by VaxiJen for Different Viral Pathogens between 2017-2021-A Scoping Review.Vaccines (Basel). 2022 Oct 24;10(11):1785. doi: 10.3390/vaccines10111785. Vaccines (Basel). 2022. PMID: 36366294 Free PMC article.
-
Computational construction of a glycoprotein multi-epitope subunit vaccine candidate for old and new South-African SARS-CoV-2 virus strains.Inform Med Unlocked. 2022;28:100845. doi: 10.1016/j.imu.2022.100845. Epub 2022 Jan 15. Inform Med Unlocked. 2022. PMID: 35071728 Free PMC article.
-
Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.Virus Res. 2021 Jun;298:198401. doi: 10.1016/j.virusres.2021.198401. Epub 2021 Mar 26. Virus Res. 2021. PMID: 33781798 Free PMC article.
-
Strategies for COVID-19 Epidemiological Surveillance in India: Overall Policies Till June 2021.Front Public Health. 2021 Jul 22;9:708224. doi: 10.3389/fpubh.2021.708224. eCollection 2021. Front Public Health. 2021. PMID: 34368070 Free PMC article.
References
-
- Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C., Chen H., Chen J., Luo Y., Guo H., Jiang R., Liu M., Chen Y., Shen X., Wang X., Zheng X., Zhao K., Chen Q., Deng L.L.F., Yan B., Zhan F., Wang Y., Xiao G., Shi Z. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7. - DOI - PMC - PubMed
-
- Ksiazek T., Erdman D., Goldsmith C., Zaki S., Peret T., Emery S., Tong S., Urbani C., Comer J., Lim W., Rollin P., Dowell S., Ling A., Humphrey C., Shieh W.J., Guarner J., Paddock C., Rota P., Fields B., Anderson L. A novel coronavirus associated with severe acute respiratory syndrome. New Engl. J. Med. 2003;348:1953–1966. doi: 10.1056/NEJMoa030781. - DOI - PubMed
-
- Groot R.D., Baker S., Baric R., Brown C., Drosten C., Enjuanes L., Fouchier R., Galiano M., Gorbalenya A., Memish Z., Perlman S., Poon L., Snijder E., Stephens G., Woo P., Zaki A., Zambon M., Ziebuhr J. Middle east respiratory syndrome coronavirus (mers-cov): Announcement of the coronavirus study group. J. Virol. 2013;87 doi: 10.1128/JVI.01244-13. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous